Poll

Discussions With Patients: Medical Marijuana

Author(s):

Psychiatric Times Editors

As our knowledge about herbal cannabis, the endocannabinoid system, and cannabinoid pharmacology expands, should psychiatrists discuss these issues with their patients?

OneLineMan/Shutterstock

Do you discuss medical marijuana/cannabis use for medical/psychiatric issues with your patients?

Yes
No
Related Videos
schizophrenia
clozapine
brain
Andrii Yalaanskyi/AdobeStock
Africa Studio/AdobeStock
VectorStory/AdobeStock
Julyuela/AdobeStock
Michael/AdobeStock
Cendece_AdobeStock
Related Content
delirium
May 9th 2025

Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial

Joshua Robak, MD Nishi Modi, MBBS Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
deprescribing
May 5th 2025

Deprescribing: Does the Term Belong in the Psychiatric Lexicon?

Joseph F. Goldberg, MD
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
benzodiazepine
April 16th 2025

Benzodiazepine Discontinuation Associated With Increased Mortality in Patients on Stable, Long-Term Benzodiazepines

Geena Sutherland, MD Nancy Kartiko, MD Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
pharmacist
April 16th 2025

Treating Schizophrenia: Bringing Together Pharmacists and Clinicians for Patient Care

Michael McGuire, PharmD
© 2025 MJH Life Sciences

All rights reserved.